Systems | Development | Analytics | API | Testing

Image credits: Julia Sowells With the onset of the COVID pandemic in 2020, the use of telemedicine and telehealth services has soared. An article by McKinsey estimated that in 2021, the use of telehealth was 38 times higher than pre-COVID years.

The pandemic changed our healthcare behaviors. Planned hospital and doctor visits were reduced while telemedicine, for physical and mental health, increased. As healthcare providers and insurers/payers worked through mass amounts of new data, our health insurance practice was there to help.

Vaccine development became the top priority for the life sciences industry – delivering new vaccines at unprecedented speed and maneuvering large-scale production processes. Numerous factors helped accelerate the vaccine roll-out including prior research, genome sequencing, jumping the FDA approval queue and a plethora of testing volunteers. So now that we’ve experienced these advancements, how can the industry keep momentum to speed-up innovative solutions across healthcare?

A global leader in pharmaceuticals found themselves faced with a unique spin on a common challenge: Their biopharmaceutical division — responsible for producing vaccines and generating over $1 billion in annual sales — was struggling to turn raw data into trusted insights. Data underlies everything the global pharmaceutical company does, however, without data they can trust, they would be at risk of taking longer to get vaccines to market and incurring higher expenses along the way.

Most general guidelines for requirements management are an acceptable starting point for medical device developers. Basic instructions for requirements planning, defining, prioritizing, etc. applies to almost any industry. However, medical device requirements management has to include some extraordinarily important things that some other industries can get by without. Compliance, risk management, and traceability are central to medical device development.

A new study from McKinsey warns that profit pools in the healthcare industry are likely to be flat due to the ongoing effects of the COVID-19 pandemic. To combat this stagnancy, the study identifies a number of opportunities for innovation in the industry.

A leading company in the healthcare industry has been providing value and care to its clients worldwide for over 20 years. With more than 5,000 employees, this healthcare provider focuses on developing, manufacturing, and distributing continuous glucose monitoring systems for diabetes management.